全球动物用药品市场规模、份额、趋势和成长分析报告（2026-2034）

预计兽用治疗市场将从 2025 年的 578.6 亿美元成长到 2034 年的 1,014.7 亿美元，2026 年至 2034 年的复合年增长率为 6.44%。

全球兽药市场持续成长，主要得益于人们对动物健康和福利日益增长的关注。宠物饲养量的增加、畜牧业的扩张以及预防和治疗动物疾病需求的不断增长，都推动了兽药及治疗方法的需求。兽药包括疫苗、感染疾病物、驱虫药以及其他旨在改善动物健康的药物。随着动物医疗保健体系的日益完善，无论是在已开发地区还是开发中国家地区，最新兽药治疗方法的应用都在显着增加。

市场成长受多种因素驱动，包括动物疾病的蔓延、人们对通用感染疾病的认识不断提高，以及确保畜牧业食品安全的需求。各国政府和农业组织正在推广动物健康计划，以预防疾病爆发并提高生产力。此外，药物研发和诊断技术的进步也使得治疗更加有效。宠物饲主越来越愿意在先进的兽医护理上投入资金，这也促进了市场扩张。

未来，随着研发过程中新治疗方法的不断涌现，兽医市场预计将进一步扩张。生物技术和精准医疗将在动物标靶治疗的研发中发挥越来越重要的作用。包括远端监测和远端兽医服务在内的数位健康技术也有望提升兽医服务的品质。随着全球对动物性食品需求的成长以及宠物饲养量的持续上升，兽医市场预计将保持强劲成长动能。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球动物用药品市场：依产品类型划分

• 市场分析、洞察与预测
• 製药
• 疫苗
• 药用饲料添加剂

第五章 全球动物用药品市场：依动物类型划分

• 市场分析、洞察与预测
• 伴侣
• 家畜

第六章 全球动物用药品市场：依给药途径划分

• 市场分析、洞察与预测
• 口服
• 肠外
• 外用

第七章 全球动物用药品市场：依通路划分

• 市场分析、洞察与预测
• 动物医院
• 动物诊所
• 药局和药局
• 其他的

第八章：全球动物用药品市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Zoetis
  • Intervet Inc.（Merck Animal Health）
  • Elanco
  • Merial
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Vetoquinol SA
  • IDEXX Laboratories Inc
  • Virbac

The Veterinary Therapeutics Market size is expected to reach USD 101.47 Billion in 2034 from USD 57.86 Billion (2025) growing at a CAGR of 6.44% during 2026-2034.

The global veterinary therapeutics market has grown steadily due to increasing attention to animal health and welfare. Rising pet ownership, expanding livestock industries, and the growing need to prevent and treat animal diseases have fueled demand for veterinary medicines and treatments. Veterinary therapeutics include vaccines, anti-infectives, parasiticides, and other pharmaceutical products designed to improve animal health. As animal healthcare systems become more advanced, the adoption of modern veterinary treatments has increased significantly across both developed and developing regions.

Market growth is driven by several factors, including the rising prevalence of animal diseases, the growing awareness of zoonotic diseases, and the need to ensure food safety in livestock production. Governments and agricultural organizations are promoting animal health programs to prevent disease outbreaks and improve productivity. Additionally, technological advancements in drug development and diagnostics are enabling more effective treatments. The increasing willingness of pet owners to spend on advanced veterinary care is also contributing to market expansion.

In the future, the veterinary therapeutics market is expected to expand further as research and innovation lead to new treatment options. Biotechnology and precision medicine are likely to play a larger role in developing targeted therapies for animals. Digital health technologies, including remote monitoring and tele-veterinary services, may also enhance veterinary care. As global demand for animal-derived food products rises and pet ownership continues to grow, the market for veterinary therapeutics will remain strong.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Drugs
• Vaccines
• Medicated Feed Additives

By Animal Type

• Companion
• Livestock

By Route of Administration

• Oral
• Parenteral
• Topical

By Distribution Channels

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others

COMPANIES PROFILED

• Zoetis, Intervet Inc Merck Animal Health, Elanco, Merial, Bayer AG, Boehringer Ingelheim International GmbH, Ceva, Vetoquinol SA, IDEXX Laboratories Inc, Virbac
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY THERAPEUTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Medicated Feed Additives Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY THERAPEUTICS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type
• 5.2. Companion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Livestock Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY THERAPEUTICS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY THERAPEUTICS MARKET: BY DISTRIBUTION CHANNELS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channels
• 7.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmacies & Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Animal Type
  • 8.2.3 By Route Of Administration
  • 8.2.4 By Distribution Channels
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Animal Type
  • 8.3.3 By Route Of Administration
  • 8.3.4 By Distribution Channels
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Animal Type
  • 8.4.3 By Route Of Administration
  • 8.4.4 By Distribution Channels
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Animal Type
  • 8.5.3 By Route Of Administration
  • 8.5.4 By Distribution Channels
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Animal Type
  • 8.6.3 By Route Of Administration
  • 8.6.4 By Distribution Channels
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VETERINARY THERAPEUTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 Intervet Inc. (Merck Animal Health)
  • 10.2.3 Elanco
  • 10.2.4 Merial
  • 10.2.5 Bayer AG
  • 10.2.6 Boehringer Ingelheim International GmbH
  • 10.2.7 Ceva
  • 10.2.8 Vetoquinol S.A
  • 10.2.9 IDEXX Laboratories Inc
  • 10.2.10 Virbac